Table 1: Extraction progress as of ToxRefDB v2 release.
Over 65% of the studies have been curated with dose-response, quantitative data extracted. Priority was given to chronic (CHR) and sub-chronic (SUB) OPP DERs and NTP study reports, which are completed. The remaining studies are predominantly from the published literature and pharmaceutical companies. A) The number of studies per source by study type. B) The number of chemicals per study type.
| A. Number of studies by source | ||
|---|---|---|
| Study type | Study source | Number of studies extracted |
| CHR | NTP | 347 |
| CHR | OPP DER | 1,079 |
| CHR | OpenLit | 9 |
| DEV | NTP | 10 |
| DEV | OPP DER | 958 |
| DEV | OpenLit | 1 |
| DEV | Other | 6 |
| MGR | OPP DER | 345 |
| MGR | OpenLit | 1 |
| MGR | Other | 20 |
| SAC | NTP | 59 |
| SAC | OPP DER | 25 |
| SUB | NTP | 247 |
| SUB | OPP DER | 769 |
| SUB | OpenLit | 6 |
| Total | 3,882 | |
| B: Number of chemicals for each study type | |
|---|---|
| Study type | Number of chemicals |
| ACU | 10 |
| CHR | 663 |
| DEV | 710 |
| DNT | 124 |
| MGR | 458 |
| NEU | 18 |
| OTH | 18 |
| REP | 77 |
| SAC | 191 |
| SUB | 659 |
| Total chemicals | 1142 |